Search results
Results From The WOW.Com Content Network
Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...
BARCELONA, Spain, July 29, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE: GRF, MCE: GRF.P NASDAQ: GRFS), one of the world’s leading producers of plasma-derived medicines, today announced that the United States Food and Drug Administration (FDA) has approved an expanded label for XEMBIFY ®, the company’s 20% subcutaneous immunoglobulin (SCIg), to include treatment-naïve patients with primary ...
Click here for the latest stock market news and in-depth analysis, including events that move stocks Read the latest financial and business news from Yahoo Finance Show comments
Shares of Marvell Technology (NASDAQ: MRVL) were surging today after the semiconductor maker posted better-than-expected results in its third-quarter earnings report, driven in part by strong AI ...
Click here for the latest stock market news and in-depth analysis, including events that move stocks. Read the latest financial and business news from Yahoo Finance. Show comments.
Micrograph showing a PD-L1 positive lung adenocarcinoma.Positive immunostaining can predict response to the treatment.. PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitor anticancer drugs that block the activity of PD-1 and PDL1 immune checkpoint proteins present on the surface of cells.
The acquisition includes Engineering News-Record, Architectural Record, Dodge and Sweet's. [3] McGraw-Hill Construction has been renamed Dodge Data & Analytics. [4] On February 17, 2020, Dell Technologies sold its RSA Security business to a group led by STG in an all-cash transaction for $2.075 billion. [5]
Test and measurement technology company Keysight Technologies (NYSE: KEYS) stock is up a whopping 14.3% in the week to Friday morning. The move comes as the market warmed to its third-quarter ...